Published November 14, 2025 | Version v1
Publication Open

Zn containing mesoporous bioglasses with enhanced textural and antibacterial properties produced by three modifications of the sol-gel method

  • 1. Institute of Biomaterials and Bioengineering, Faculty of Natural Sciences and Technology, Riga Technical University, Paula Valdena Street 3 k-1, LV-1048, Riga, Latvia
  • 2. Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Riga, Latvia
  • 3. Department of Prosthodontics, Faculty of Health Sciences, School of Dentistry, Aristotle University of Thessaloniki, Thessaloniki, GR-54124, Greece
  • 4. Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece
  • 5. Department of Botany, School of Biology, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece
  • 6. School of Chemistry, University College Dublin, Belfield, Dublin, 4, Ireland
  • 7. Institute of Materials and Surface Technologies, Riga Technical University, P. Valdena str. 7, LV-1048, Riga, Latvia

Description

Mesoporous bioactive glasses (MBGs) have potential applications in bone tissue regeneration around tooth implant and local drug delivery. Small amounts of zinc added to their composition could additionally provide antibacterial and ossteoinductive and anti-inflammatory properties. In this study, zinc-containing mesoporous bioactive glasses (5ZnO–25CaO–70SiO₂) were synthesised using three modified surfactant-assisted sol-gel methods: dilute water (MZ1), Stöber (MZ2), and microemulsion-assisted (MZ3). X-ray diffraction (XRD) analysis confirmed that MZ1 and MZ3 were amorphous, while MZ2 exhibited a ZnO crystalline phase. The synthesised particles showed uniform morphology with sizes ranging from 10 to 500 nm. Brunauer–Emmett–Teller (BET) analysis revealed that MZ1 had the highest specific surface area (726 m²/g), approximately 4.1 times higher than MZ3 (176 m²/g). Haemolysis testing showed that MZ1 and MZ2 were non-haemolytic, whereas MZ3 caused lysis of erythrocytes. All samples were biocompatible with periodontal ligament fibroblasts, maintaining cell viability above 80% after three days of incubation. Antibacterial assays indicated that MZ2 exhibited over 60% inhibition of P. intermedia in a dose-dependent manner, but only ~20% inhibition of P. gingivalis. MZ2 demonstrated a bacteriostatic effect and was most effective in reducing anaerobic bacterial populations among all tested groups. These results highlight the potential of Zn-containing mesoporous bioactive glasses as multifunctional biomaterials for periodontal tissue engineering, suitable for such applications as scaffolds, bone cements, bone-filling granules, and antibacterial implant coatings. Furthermore, MZ2 material due to its antimicrobial properties, can potentially be a material of choice in periodontitis/peri-implantitis therapy applications.

Files

s10856-025-06960-w.pdf

Files (2.5 MB)

Name Size Download all
md5:485edf01981ccb37502929c8bfa4b3f1
2.5 MB Preview Download

Additional details

Funding

European Commission
RegrOssBio - Injectable biomimetic octacalcium phosphate based composites with antibacterial action for implant re-ossteointegration 101106882
European Commission
BBCE - Baltic Biomaterials Centre of Excellence 857287